Doxycycline in Type II Diabetes

Launched by MOSTAFA BAHAA · Mar 24, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a medication called doxycycline on people with newly diagnosed Type 2 diabetes. Type 2 diabetes is a condition where the body has trouble using insulin, a hormone that helps control blood sugar levels. The researchers want to see if doxycycline can help improve blood sugar control and overall health in people with this condition.

To participate in this trial, you need to be over 40 years old and have recently been diagnosed with Type 2 diabetes, with a specific blood test result indicating high blood sugar levels. Unfortunately, if you have certain health issues like chronic kidney disease or liver problems, or if you are pregnant or nursing, you won’t be able to join. If you are eligible and decide to participate, you will receive the study medication and be monitored by healthcare professionals who will check your health and diabetes management throughout the trial. This study is currently looking for participants, so if you or someone you know fits the criteria, it could be an opportunity to contribute to important diabetes research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female sex more than 40 years old Newly diagnosed type II diabetes. HbA1c more than 6.5
• Exclusion Criteria:
• • Patient with chronic kidney disease, hepatic disorders, mental and psychiatric disorders, pregnancy, and lactation